MedTrace Logo

Cerebral Microembolism in Cardiology

NCT03802760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-11-08

No results posted yet for this study

Summary

During different interventional cardiology procedures we aim to identify cerebral microemboli load. Further we aim to differentiate the quality and the quantity of cerebral microemboli.We will measure cerebral microemboli in different interventional phases, e.g. during valve deployment, rapid pacing, post-implantation.

Conditions

  • Cerebral Embolism

Interventions

DEVICE

Transcranial Doppler (TCD) ultrasound measurement

Non-invasive measurement of cerebral embolic load and blood flow using TCD

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-24
Primary Completion
2022-02-24
Completion
2022-11-06

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03802760 on ClinicalTrials.gov